Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Mayweather, Pacquiao agree to USADA drug testing

Published 03/13/2015, 03:09 PM
Updated 03/13/2015, 03:09 PM
© Reuters. Boxing: Mayweather vs Pacquiao-Press Conference

(Reuters) - Floyd Mayweather and Manny Pacquiao have agreed to take part in a U.S. Anti-Doping Agency (USADA) Olympic-style testing program ahead of their May 2 mega-bout in Las Vegas, USADA said on Friday.

Drug testing had long been a major stumbling block in bringing together the biggest drawcards of their generation, but USADA confirmed both fighters have consented to rules established under the World Anti-Doping Code and the World Anti-Doping Agency (WADA) banned-substance list.

"It's a strong statement of the importance of clean and safe competition to have these two fighters voluntarily agree to have a WADA level anti-doping program implemented for this fight," said USADA CEO Travis Tygart in a statement. "We commend them for their stand for clean sport and the message it sends to all those who want to compete clean at the highest levels of all sport."

The welterweight showdown between the undefeated Mayweather (47-0) and Pacquiao (57-5-2) is projected to be the most lucrative ever in boxing but was delayed for years over the American's demands that his Philippines' opponent submit to drug testing.

Five-division world champion Mayweather, who is known for his shrewd business acumen, had been expected to meet Pacquiao in 2010 until negotiations collapsed over his demand for random drug testing.

Mayweather has hinted at illegal methods by questioning how Pacquiao could have won world titles in an unprecedented eight weight classes.

The defense-minded Mayweather and the aggressive Pacquiao have already received education on the USADA program and have enrolled in USADA's registered testing pool by providing their whereabouts so they can be located for out-of-competition testing prior to the fight.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

USADA will also perform in-competition testing after the fight.

Both fighters agreed to both blood and urine testing.

Samples collected by USADA will be sent to a WADA-accredited laboratory for analysis, including testing for human growth hormone (HGH) and erythropoietin (EPO).

USADA and the Nevada State Athletic Commission are working collaboratively and will share all relevant information about the program including all test results.

(Story refiled to restore dropped words in first para)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.